Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine 10-Day Regimen for Elderly AML
NCT01633099Phase 3Unknown
- Start
- May 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML). Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01633099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633099.